MarketScreener Editorial Features Protagonist Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-16 EST			5-day change	1st Jan Change
91.54 ^USD	-3.43%		+3.36%	+137.15%

12-06	Protagonist Therapeutics, Inc. and Takeda Pharmaceutical Company Limited Present Longer-Term Data At ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera	CI
11-06	Protagonist Therapeutics Q3 net loss widens to $39.3 mln	RE

	Today on Wall Street: It's just a period of market normalization	October 12, 2021 at 09:16 am
	Analyst recommendations: Cigna, Halliburton, Nike, Nio, Trex...	October 12, 2021 at 06:20 am

No results for this search